Arpida (SIX: ARPN) is a biopharmaceutical company headquartered in Reinach, near Basel, Switzerland with operations in Switzerland and the USA. It focuses on novel drugs that seek to overcome the growing problem of microbial resistance. Arpida’s leading product candidate is intravenous iclaprim, an antibiotic that targets severe infections requiring hospital treatment, including those caused by methicillin-resistant Staphylococcus aureus (MRSA).
View Top Employees from Arpida| Website | http://www.arpida.com |
| Revenue | $9.2 million |
| Employees | 28 (14 on RocketReach) |
| Founded | 1997 |
| Technologies |
JavaScript,
HTML,
Google Analytics
+9 more
(view full list)
|
| Industry | Pharmaceuticals, Pharmaceutical Manufacturing, Drug Discovery, Healthcare, Biotechnology, Drug Manufacturing & Research |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies, SIC Code 2834 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies |
Looking for a particular Arpida employee's phone or email?
Arpida Questions
The Arpida annual revenue was $9.2 million in 2024.
Alfredo Bruno is the Head of Antifungals of Arpida.
14 people are employed at Arpida.
The NAICS codes for Arpida are [32541, 32, 325, 3254].
The SIC codes for Arpida are [283, 28, 2834].
Top Arpida Employees
Related Companies
